Insider Trades of NOVARTIS AG
Click on the column header to resort 'ascending (^) or descending (v).
Individual Insider Trades
| Company | Relation | Last Date |
Tran | OwnerType | Shares Traded | Last Price | Shares Held |
|---|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Beneficial Owner (10%) | 09/20/2012 | Sell | indirect | 1,551,896 | 19.42 | 4,051,002 |
| IDENIX PHARMACEUTICALS INC | Other | 02/23/2012 | Buy | indirect | 84,893 | 2.41 | 33,320,674 |
| IDENIX PHARMACEUTICALS INC | Other | 11/22/2011 | Buy | indirect | 50,530 | 2.41 | 33,235,781 |
Latest News Headlines
UPDATE: Goldman Sachs Chief Confident Euro will Survive - Report 11:51AM ET - Dow Jones Business News
Goldman Sachs Chief Confident Euro will Survive - Report 10:24AM ET - Dow Jones Business News
Google CEO Schmidt Defends Tax Affairs amid Fresh Claims - Newspapers 10:20AM ET - Dow Jones Business News
GRAVITY Reports First Quarter of 2013 Results 9:00AM ET - GlobeNewswire
MARKET SNAPSHOT: Stock Rally's Breadth Is A Sign Of Strength, Froth 8:05AM ET - Dow Jones Business News
View All